When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 21 Apr 2025
Last updated: 27 Feb 2025

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • dysuria (in women)
  • lymphadenopathy
  • genital ulcer
  • oral ulcer
  • fever

Other diagnostic factors

  • tingling sensation
  • headache/aseptic meningitis

Risk factors

  • HIV infection (risk factor for clinical disease)
  • use of immunosuppressive medications (risk factor for clinical disease)
  • female sex (risk factor for seropositivity)
  • black race (risk factor for seropositivity)
  • increasing age (risk factor for seropositivity)
  • high-risk sexual behaviour (risk factor for seropositivity)
  • lack of condom use (risk factor for seropositivity)

Diagnostic investigations

1st investigations to order

  • HSV polymerase chain reaction (PCR)
  • viral culture

Investigations to consider

  • Glycoprotein G-based type-specific serology (gG1 and gG2)

Treatment algorithm

Contributors

Authors

Benjamin D. Lorenz, MD

Assistant Professor

Division of Hospital Medicine

MedStar Georgetown University Hospital

Washington

DC

Disclosures

BDL declares that he has no competing interests. Since completing the 2024 review, BDL has become an employee of Moderna and has resigned as a contributor.

Acknowledgements

Dr Benjamin D. Lorenz would like to gratefully acknowledge Dr Christine Johnson and Dr Anna Wald, previous contributors to this topic.

Disclosures

CJ reports funding from AiCuris; grants from Agenus, Gilead, Genocea, Sanofi, and Vical to conduct clinical research studies; and royalties from Up To Date. AW reports grants from Agenus, Gilead, Genocea, Sanofi, and Vical to conduct clinical research studies. AW receives royalties from Up To Date. AW is an NIH grant recipient (NIH AI30731 and AI071113) and a consultant for Aicuris, Eisai, and Amgen.

Peer reviewers

Giuseppe Pizzo, DDS

Associate Professor

Department of Surgical, Oncological and Oral Sciences

School of Dentistry

University of Palermo

Palermo

Italy

Disclosures

GP declares that he has no competing interests.

Paul Adamson, MD, MPH

Assistant Clinical Professor of Medicine

David Geffen School of Medicine

University of California, Los Angeles

Los Angeles

CA

Disclosures

PA declares that he has no competing interests.

Nicholas Van Wagoner, MD, PhD

Associate Professor of Medicine

University of Alabama

Birmingham

AL

Disclosures

NVW declares that he has no competing interests.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Morris-Cunnington M, Brown D, Pimenta J, et al. New estimates of herpes simplex virus type 2 seroprevalence in England: 'high' but stable seroprevalence over the last decade. Sex Transm Dis. 2004;31:243-246. Abstract

Centers for Disease Control and Prevention. Morbidity and mortality weekly report: sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication].Full text

Patel R, Kennedy OJ, Clarke E, et al. 2017 European guidelines for the management of genital herpes. Int J STD AIDS. 2017 Dec;28(14):1366-79.Full text  Abstract

American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 220: management of genital herpes in pregnancy. May 2020 [internet publication].Full text

British Association for Sexual Health & HIV; Royal College of Obstetricians and Gynaecologists. Management of genital herpes in pregnancy. Oct 2014 [internet publication].Full text

Reference articles

A full list of sources referenced in this topic is available here.

Use of this content is subject to our disclaimer